|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0086 USD | 0.00% |
|
0.00% | -95.41% |
| 03-05 | Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc.. | CI |
| 02-16 | Peak Bio, Inc. announced that it has received $2.238 million in funding | CI |
Peak Bio, Inc. announced that it has entered into a forward purchase agreement to issue common shares at a purchase price of $10 per share for the aggregate gross proceeds of $10,000,000 on April 7, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -95.41% | 195K | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
PEAK BIO, INC. 
